Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8F5H

SARS-CoV-2 S2 helix epitope scaffold

8F5H の概要
エントリーDOI10.2210/pdb8f5h/pdb
分子名称S2hlx_EX_19 (2 entities in total)
機能のキーワードepitope scaffold, s2 helix, spike, immune system
由来する生物種Mus musculus
タンパク質・核酸の鎖数2
化学式量合計33833.18
構造登録者
Kapingidza, A.B.,Wrapp, D.,Winters, K.,Azoitei, M.L. (登録日: 2022-11-14, 公開日: 2023-10-11, 最終更新日: 2024-02-28)
主引用文献Kapingidza, A.B.,Marston, D.J.,Harris, C.,Wrapp, D.,Winters, K.,Mielke, D.,Xiaozhi, L.,Yin, Q.,Foulger, A.,Parks, R.,Barr, M.,Newman, A.,Schafer, A.,Eaton, A.,Flores, J.M.,Harner, A.,Catanzaro Jr., N.J.,Mallory, M.L.,Mattocks, M.D.,Beverly, C.,Rhodes, B.,Mansouri, K.,Van Itallie, E.,Vure, P.,Dunn, B.,Keyes, T.,Stanfield-Oakley, S.,Woods, C.W.,Petzold, E.A.,Walter, E.B.,Wiehe, K.,Edwards, R.J.,Montefiori, D.C.,Ferrari, G.,Baric, R.,Cain, D.W.,Saunders, K.O.,Haynes, B.F.,Azoitei, M.L.
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes.
Nat Commun, 14:7897-7897, 2023
Cited by
PubMed Abstract: Immune responses to SARS-CoV-2 primarily target the receptor binding domain of the spike protein, which continually mutates to escape acquired immunity. Other regions in the spike S2 subunit, such as the stem helix and the segment encompassing residues 815-823 adjacent to the fusion peptide, are highly conserved across sarbecoviruses and are recognized by broadly reactive antibodies, providing hope that vaccines targeting these epitopes could offer protection against both current and emergent viruses. Here we employ computational modeling to design scaffolded immunogens that display the spike 815-823 peptide and the stem helix epitopes without the distracting and immunodominant receptor binding domain. These engineered proteins bind with high affinity and specificity to the mature and germline versions of previously identified broadly protective human antibodies. Epitope scaffolds interact with both sera and isolated monoclonal antibodies with broadly reactivity from individuals with pre-existing SARS-CoV-2 immunity. When used as immunogens, epitope scaffolds elicit sera with broad betacoronavirus reactivity and protect as "boosts" against live virus challenge in mice, illustrating their potential as components of a future pancoronavirus vaccine.
PubMed: 38036525
DOI: 10.1038/s41467-023-43638-9
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 8f5h
検証レポート(詳細版)ダウンロードをダウンロード

238268

件を2025-07-02に公開中

PDB statisticsPDBj update infoContact PDBjnumon